Managed Care Matters - Quest Diagnostics

Document Sample
Managed Care Matters - Quest Diagnostics Powered By Docstoc
					Managed Care
                                                                                                                                    Managed Care Newsletter
                                                                                                                                    Winter 2005

Matters                                                                                                           Prescriptions Made Simple
                                                                                                                  Quest Diagnostics now
                                                                                                                  offers Care360™ ePrescribing
                                                                                                                  service solution
                                                                                                                  Electronic prescribing offers the opportunity
A New Test Means Better Care for                                                                                  for significant quality improvements and
                                                                                                                  significant cost savings – estimated to be as
Metastatic Breast Cancer Patients                                                                                 much as $27 billion industry-wide.
Quest Diagnostics now offers the CellSearch™
                                                                                                                  Quest Diagnostics, a leader in physician
Circulating Tumor Cell Kit
                                                                                                                  connectivity products, has launched an
Quest Diagnostics recently agreed with Veridex, LLC, a Johnson & Johnson                                          ePrescribing module within our Care360
company, to be the only national commercial reference laboratory to offer                                         physician offering.
Veridex’s CellSearch Circulating Tumor Cell Kit. CellSearch is a new cancer
                                                                                                                  Now, there’s a simpler, easier way for your
diagnostic technology that identifies and counts circulating tumor cells in
                                                                                                                  physicians to order, refill and manage patient
blood samples from patients being treated for metastatic breast cancer.
                                                                                                                  prescriptions and help eliminate data
In January 2004, the U.S. Food and Drug Administration cleared CellSearch                                         omissions and errors.
to be used for the enumeration of circulating tumor cells of epithelial origin
                                                                                                                  Care360 ePrescribing offers:
in whole blood.
                                                                                                                   Electronic script submission
Circulating tumor cells are present in the blood when a primary cancer                                             Formulary presentation through RxHub
sheds tumor cells into the circulatory system. Cancer metastasis occurs
                                                                                                                   or payer-specific uploads
when circulating tumor cells begin to grow in distant locations in the body.
                                                                                                                   Diagnostic lab history
The ability to identify and count circulating tumor cells has the potential
                                                                                                                   Prescription history
to improve the care oncologists administer to their patients with metastatic
breast cancer.                                                                                                     Drug-to-drug and drug-to-allergy
                                                                                                                   interaction warnings
Knowing the number of circulating tumor cells in the blood may help
                                                                                                                   Integration with existing physician office
oncologists make decisions about patients’ treatment earlier than previously
                                                                                                                   IT systems
possible. Until now, physicians had to wait three months or longer before
they could use medical imaging to determine if a specific treatment was                                            Anytime, anywhere access
beneficial to the patient.                                                                                        Care360 ePrescribing reduces paperwork
“This important new test has the potential to help oncologists better care                                        because prescriptions are charted electroni-
for patients with metastatic breast cancer,” said Surya N. Mohapatra, Ph.D.,                                      cally, alongside lab results, thereby reducing
President and Chief Executive Officer at Quest Diagnostics. “We are excited                                       dependency on paper charts for filling
to offer this test, which strengthens our position in oncology testing as a                                       prescriptions or responding to inquiries.
trusted resource for doctors and their patients.”                                                                 ePrescribing also increases time for patient
                                                                                                                  care by reducing time spent on the phone
CellSearch’s value was substantiated by a study published on August 19, 2004,                                     with pharmacies – allowing a new prescription
in the New England Journal of Medicine, which demonstrated that the number                                        to be created and sent in three easy steps.
of circulating tumor cells is predictive of progression-free survival and overall                                 The service also enhances quality of care by
survival in metastatic breast cancer patients.                                                                    identifying drug-interactions within a pre-
For more information about CellSearch Circulating Tumor Cells, please call                                        scription and efficiently sharing patient lab
Quest Diagnostics Nichols Institute toll-free at 800-642-4657, extension 2906.                                    and prescription history with other Care360
    Cristofanilli, M, Budd, GT, Ellis, MJ, et al. Circulating Tumor Cells, Disease Progression, and Survival in
                                                                                                                  medical providers.
    Metastatic Breast Cancer. N Engl J Med. 2004; 351:781–791.                                                                                  continued on page 2
Quest Diagnostics Presents:                                                                             An Appropriate Partner
The Art of Women’s Health                                                                               A partnership with Quest Diagnostics
A seven-part television series focusing on current women’s issues                                       helps ensure successful launch, training
Did you know?                                                                                           and deployment and, most importantly,
  Women can lose up to 20 percent of their bone mass in the five to seven                               provider adoption.
 years following menopause, making them more susceptible to osteoporosis.i                                Relationships with 300,000 physician
  Of the 78,054 babies born each week in the U.S., 8,826 of those babies                                  customers
 are born to mothers who received inadequate prenatal care.ii                                             800 trained and dedicated Sales
  Approximately 6.1 million American women are affected by infertility.iii                                Representatives
  It is estimated that 231,910 American women will die from breast cancer                                 200 locally distributed Field IT Staff
 this year alone.iv
                                                                                                          24 x 7 Help Desk Support
  Every minute, one woman dies from cardiovascular disease.v
                                                                                                          Integrated into the existing workflow
In an effort to inform more and more women about the challenging health
                                                                                                          of providers nationally
issues facing them today, Quest Diagnostics is underwriting ‘The Art of
Women’s Health,’ a seven-part series that will begin airing on PBS in April                             A prescription management component of
2005. Viewers will have the chance to hear inspiring stories from a number                              the eMaxx® Physician Portal, ePrescribing
of women as they recount their experiences with some of the following                                   simply requires a PC and high-speed
health issues: fertility, well-women exams, prenatal care, heart disease,                               Internet access to deliver significant time
breast cancer and osteoporosis, to name a few.                                                          and cost-savings to its users. For more
As a leader in women’s health, Quest Diagnostics is proud to help underwrite                            information about Care360 Physician Office
this unique series as part of our commitment to our patients. Supporting                                Solutions contact your Quest Diagnostics
today’s women with comprehensive testing and information is one of Quest                                Account Executive.
Diagnostics’ most important goals.
      National Osteoporosis Foundation,
      March of Dimes,
      American Society for Reproductive Medicine
      American Cancer Society, 2004.
      Heart Disease and Stroke Statistics – 2004 Update, American Heart Association

                                                                                                        We look forward to seeing you at these conferences!
                                                                                                     have been assembled for this meeting.
                                                                                                     most experienced and forward-thinking leaders
                                                                                                     unique, discussion-based forum. Some of the
                                                                                                     solutions, as it will convene all stakeholders in a
                                                                                                     significant strides in implementing actionable
                                                                                                     cance. The 2005 conference hopes to achieve
                                                                                                     conference initiated a dialog of national signifi-
                                                                                                     Wall Street Journal and CNBC, the 2004 executive
                                                                                                     through February 1, 2005. Co-sponsored by the
                                                                                                     Washington D.C. is scheduled from January 30
                                                                                                     The 2nd Annual World Health Care Congress in
                                                                                                                 2005 World Health Care Congress
                                                                                                     is now demanding.
                                                                                                     the quality measures the consumerism movement
                                                                                                     California. The Forum will focus on PPOs, and
                                                                                                     Laguna Niguel Spa and Resort in Dana Point,
                                                                                                     January 23 through 25, 2005, at the Ritz-Carlton’s
                                                                                                     The 2005 Annual PPO Forum is scheduled from
                                                                                                      Organizations (AAPPO)
                                                                                                       American Association of Preferred Provider
    GRAPHICS                                                         Pennshauken, NJ 08110            conferences in early 2005:
 CONTEMPORARY                                                        1533 Union Avenue                we will be participating at the following
                                                                     c/o Contemporary Graphics        Quest Diagnostics is pleased to announce that
FIRST CLASS MAIL                                                                                     Coming Soon to a Conference Near You
                                                                                 Quest Diagnostics

Shared By: